Solid Biosciences SLDB Cash Flow Statement (2017-2026)

NASDAQ SLDB
$7.10 +0.08 (+1.14%)
As of: Nov 10, 2026 · 2:12 PM EST
Reported Financials

Solid Biosciences Quarterly Cash Flow Statement

Periods 39 quarters
Latest Sep 2026

Solid Biosciences reported cash from operations of -$45.55M and free cash flow of -$46.04M for the quarter ended Sep 2026, down 36.1% year over year. This cash flow statement covers 39 quarters of results from Mar 2017 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-18.61M-25.33M-25.09M-20.41M-15.15M-30.07M-24.63M-20.98M-20.34M-24.30M-25.07M-32.73M-42.60M-39.28M-39.48M-45.78M-49.79M-56.74M-54.80M-53.95M
Depreciation and DepletionDep. & Depletion
0.76M0.71M0.72M0.44M0.54M1.08M0.70M0.59M0.21M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.76M0.71M0.72M0.44M0.54M1.08M0.70M0.59M0.21M0.33M1.24M0.41M0.49M0.41M0.39M0.38M0.47M0.40M0.39M0.42M
Share-based CompensationStock Comp.
3.42M2.61M1.81M1.52M1.59M2.12M1.94M1.63M1.94M1.61M2.09M3.00M3.82M3.34M3.15M3.93M6.50M5.15M5.62M6.15M
Gains from Sales and DivestituresGains Divest
-0.08M
Other non-cash itemsOther Non-Cash
-18.24M0.63M1.02M0.57M0.58M3.99M4.75M-1.10M-0.24M-0.55M-2.04M-1.03M-0.19M0.77M
Change in Working Capital
Change in Account PayablesChange Payables
0.57M0.07M0.30M0.29M-5.91M2.75M-2.71M-0.93M0.13M-0.60M1.07M0.92M0.82M0.46M0.01M3.70M-5.26M2.32M-1.18M-1.13M
Change in Accrued ExpensesChange Accrued Exp.
2.58M-0.45M8.67M-4.97M2.57M-4.91M-1.32M0.91M-1.65M0.21M-0.38M3.31M1.62M-0.28M1.97M2.20M0.15M-0.47M-0.97M3.43M
Change in Other Operating AssetsOther Assets Change
7.12M3.27M-3.97M-2.72M-0.39M-1.26M1.82M-1.69M0.53M2.00M-0.44M0.99M-0.10M-2.02M4.08M-1.72M7.65M-0.95M1.28M-1.06M
Change in Other Operating LiabilitiesOther Liabilities Change
-3.05M-1.91M-6.17M-0.44M-0.47M-0.47M-0.39M-0.40M-0.41M-0.42M-0.43M-0.44M-0.50M-0.50M-0.51M-0.53M
Other Working Capital ChangesOther WC Changes
-10.17M-5.18M-2.20M2.72M0.39M1.26M-1.82M1.24M-1.00M-2.47M0.05M-1.39M-0.31M1.61M-4.52M1.27M-8.14M0.46M-1.79M0.52M
Cash from OperationsCash from Ops.
-20.87M-27.19M-15.88M-20.43M-34.48M-28.00M-27.47M-17.90M-20.82M-25.19M-21.47M-23.71M-29.65M-31.85M-37.41M-33.47M-53.57M-47.23M-52.59M-45.55M
Investing Activities
Capital ExpendituresCapex
0.66M0.18M1.14M0.84M0.86M0.51M0.54M0.38M0.09M0.15M0.29M0.02M0.20M0.13M0.38M0.09M0.57M0.17M0.15M0.50M
Change in Property, Plant and EquipmentChange in PP&E
-0.66M-0.18M-1.14M-0.84M-0.86M-0.51M-0.54M-0.38M-0.09M-0.15M-0.29M-0.02M-0.20M-0.13M-0.38M-0.09M-0.57M-0.17M-0.15M-0.50M
Purchase of InvestmentsInvestments Purchased
16.68M8.88M103.81M50.46M19.61M34.25M14.61M83.35M20.19M85.47M15.33M65.34M63.44M83.19M23.92M83.46M151.94M92.66M
Change in Acquisitions & DivestmentsChange Acquisitions
47.51M46.81M45.35M65.61M55.05M37.77M20.87M10.00M60.00M45.00M15.30M74.50M54.10M38.00M31.00M38.00M71.50M128.38M18.50M89.40M
Other Investing Activities (as filed)Other investing (as filed)
0.01M0.09M
Cash from Investing ActivitiesCash from Investing
30.18M37.74M-59.60M14.91M66.10M37.26M-48.23M-24.64M45.30M-38.49M-5.18M-10.99M38.57M-27.46M-32.73M-45.27M47.01M44.76M-133.59M-3.76M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
0.23M0.12M0.13M0.14M0.14M0.24M0.20M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-0.23M-0.12M-0.13M-0.14M-0.14M-0.24M-0.20M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.23M-0.12M-0.13M-0.14M-0.14M-0.24M-0.20M
Change in Capital Stock
Common Stock IssuedStock Issued
0.02M72.55M0.07M109.01M0.15M0.28M0.21M0.20M0.23M239.99M0.35M0.15M
Net Shares Issued and RepurchasedNet Shares Issued
0.02M72.55M0.07M109.01M0.15M0.28M0.21M0.20M0.23M239.99M0.35M0.15M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.02M72.55M0.07M109.01M0.15M0.28M0.21M0.20M0.23M239.99M0.35M0.15M
Other financing activities (as filed)
-4.83M-0.29M-12.89M-0.75M
Cash from Financing ActivitiesCash from Financing
0.07M0.02M0.07M0.00M74.74M0.51M107.24M5.00M3.26M6.94M189.73M-1.60M1.18M5.14M239.03M48.47M15.89M
Additional items
Change in Cash
9.37M10.58M-75.40M-5.52M106.36M9.27M-73.08M-42.53M24.98M43.56M-21.64M-31.44M15.86M130.42M-71.75M-77.57M-1.40M236.56M-137.71M-33.42M
Ending Cash Balance
157.22M166.48M93.40M50.87M75.85M119.41M97.76M66.33M82.19M212.60M140.86M63.29M61.89M298.45M160.74M127.32M
Free Cash FlowFCF
-21.53M-27.37M-17.01M-21.27M-35.34M-28.50M-28.00M-18.28M-20.91M-25.34M-21.75M-23.72M-29.85M-31.98M-37.79M-33.56M-54.13M-47.40M-52.74M-46.04M
Net Cash FlowNCF
9.37M10.58M-75.40M-5.52M106.36M9.27M-75.70M-42.53M24.98M43.56M-21.64M-31.44M15.86M130.42M-71.75M-77.57M-1.41M236.56M-137.71M-33.42M
Interest Paid
0.18M0.08M0.07M0.06M-0.04M

Solid Biosciences Cash Flow Statement API

Pull Solid Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SLDB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY